Maxime Delrue

Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?

Virginie Siguret, Sébastian Voicu, Marie Neuwirth et al. · Thrombosis Research · 2020 · 89 citations · Full text

Thrombosis, Are Antiphospholipid Antibodies, Venous Thrombosis +8

Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants

Georges Jourdi, Maxime Delrue, Alain Stépanian et al. · Thrombosis Research · 2019 · 38 citations · Full text

Thrombosis, Venous Thrombosis, Activated Charcoal +6

von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate‐to‐severe COVID‐19 patients

Maxime Delrue, Virginie Siguret, Marie Neuwirth et al. · British Journal of Haematology · 2020 · 32 citations · Full text

Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.

Sébastian Voicu, Maxime Delrue, Benjamin G. Chousterman et al. · PubMed · 2020 · 30 citations

White blood count, D‐dimers, and ferritin levels as predictive factors of pulmonary embolism suspected upon admission in noncritically ill COVID‐19 patients: The French multicenter CLOTVID retrospective study

J. Galland, Benjamin Thoreau, Maxime Delrue et al. · European Journal Of Haematology · 2021 · 23 citations · Full text